Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma Read more about Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma
Electric Field Navigated 1hz Rtms for Post-stroke Motor Recovery Trial Read more about Electric Field Navigated 1hz Rtms for Post-stroke Motor Recovery Trial
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment Read more about Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment
Use of a Probiotic Supplement to Prevent Asthma in Infants Read more about Use of a Probiotic Supplement to Prevent Asthma in Infants
The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention Read more about The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) Read more about Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP Read more about A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP
Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options Read more about Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) Read more about Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS) Read more about Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)